# Extended Stability Program Testing of Two Adenoviral HIV Vaccine Candidates

> **NIH NIH N02** · PAXVAX, INC. · 2024 · $235,429

## Abstract

The purpose of this contract is to extend the Stability programs of two adenoviral-vectored HIV vaccine candidates currently being tested in clinical trials. The required services include performing defined, established assays for testing of the product stability as negotiated with the FDA. The contract will support the stability of these two HIV vaccine candidates using pre-approved stability protocols and tests per ICH guidance and pre-approved protocols.

## Key facts

- **NIH application ID:** 11085902
- **Project number:** 75N93022P01224-P00003-0-1
- **Recipient organization:** PAXVAX, INC.
- **Principal Investigator:** JESSICA EYLER
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $235,429
- **Award type:** —
- **Project period:** 2022-09-16 → 2025-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11085902

## Citation

> US National Institutes of Health, RePORTER application 11085902, Extended Stability Program Testing of Two Adenoviral HIV Vaccine Candidates (75N93022P01224-P00003-0-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11085902. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*